Barry F. Uretsky

High Impact

Professor

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

69 h-index 558 pubs 32,057 cited

Research Areas

Links

ORCID Google Scholar Lab Website UAMS TRI Profile

OverviewAI-generated summary

Barry F. Uretsky, Professor of Internal Medicine at the University of Arkansas for Medical Sciences, investigates cardiovascular interventions and outcomes. His research focuses on the implications of percutaneous coronary intervention (PCI), particularly the role of fractional flow reserve (FFR) in assessing the functional significance of coronary stenoses and guiding treatment decisions after stent implantation. He has published on topics including the prognostic value of FFR, its stratification by coronary artery, and its use in predicting PCI outcomes.

Dr. Uretsky's work also extends to the management of chronic total occlusions (CTOs) through PCI, examining in-hospital outcomes and temporal trends, as well as the utility of distal radial access in these complex procedures. He is involved in the design and rationale of randomized clinical trials, such as the Myocardial Ischemia and Transfusion (MINT) trial. His scholarship metrics include an h-index of 69, with over 558 publications and 31,950 citations, designating him as a highly cited researcher. Key collaborators include Srikanth Vallurupalli and Malek Al‐Hawwas from the University of Arkansas for Medical Sciences.

Metrics

h-index: 69
Publications: 558
Citations: 32,057

Selected Publications

100.22 Dual-Guidewire Balloon-Catheter Design for Coronary Bifurcations (2026)

DOI OpenAlex
Knowledge gaps in revascularization strategies in the setting of type II myocardial infarction: A common clinical dilemma in contemporary practices (2026)

DOI OpenAlex
Diagnostic and prognostic utility of fractional flow reserve for in-stent restenosis (2025)

2 citations DOI OpenAlex
Target Heart Rate Formulas for Exercise Stress Testing: What Is the Evidence? (2024)

7 citations DOI OpenAlex
Use of Plaque Modification Microcatheters During Percutaneous Coronary Interventions for Chronic Total Occlusion: Insights From the PROGRESS‐CTO Registry (2024)

2 citations DOI OpenAlex
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)

2 citations DOI OpenAlex
Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction (2023)

2 citations DOI OpenAlex
Do We Still Need Aspirin in Coronary Artery Disease? (2023)

4 citations DOI OpenAlex
Impact of Post-PCI FFR Stratified by Coronary Artery (2023)

45 citations DOI OpenAlex
Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention (2023)

2 citations DOI OpenAlex
Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications (2023)

2 citations DOI OpenAlex
STAR procedure becomes SAFER: First‐in‐man case series of a new antegrade dissection re‐entry technique (2023)

10 citations DOI OpenAlex
Who Should Be the Corresponding Author, What Are Their Responsibilities, and What Email Address Should They Provide? (2023)

1 citation DOI OpenAlex
B-18 | Procedural Time and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the PROGRESS-CTO Registry (2023)

1 citation DOI OpenAlex
Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention (2022)

13 citations DOI OpenAlex